Is Genetech's halcyon era over?

Also: The American Academy of Pediatrics has started endorsing aggressive, immediate treatment for childhood obesity

September 21, 2024 Check out STAT+

Sponsored By

Exclusive: Pediatricians' obesity guidelines rest on shaky evidence about eating disorder risks The American Academy of Pediatrics has started endorsing aggressive, immediate treatment for childhood obesity. But eating disorders in young people are skyrocketing, and some doctors are alarmed about how treating obesity in children will impact their mental health. Read more. By Kate Raphael

---

---

Justin Sullivan/Getty Images Genentech, a biotech with a storied past, confronts new turbulence in the present For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist's paradise, a place where researchers have developed new therapies in-house and published high-impact papers. But the recent closure of a high-profile research group and multiple rounds of layoffs have many concerned that a storm is approaching. Read more. By Jonathan Wosen Mike Reddy for STAT Exclusive: Inside the quiet strategy pharma giants are using to fend off generics and drive up the cost of medicines Drugmakers rely on the wonky legal process of "use codes" to vastly expand their patent claims and delay the arrival of lower-cost generic medicines to the marketplace. Read more. By Ed Silverman and Michael Nolan In case you missed it... After years of being under-recognized, scientist Svetlana Mojsov shares the Lasker Award with other GLP-1 researchers. The field of psychedelics, once relegated to the fringes of science and medicine, is in the midst of both transformation and flux. These are 12 key figures in the industry we're watching. What can be done to stop the current mpox outbreak? Ten years ago, a new type of cancer treatment reached the market. Researchers are celebrating its impact — and see more work to do.

---

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Weekend Reads? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser